The ‘infodemic’ is one of the “most concerning” governance challenges of our time, undermining trust in science in the midst of the pandemic, and threatening people’s physical and mental health, warned United Nations Development Program (UNDP) Administrator Achim Steimer. While the overabundance of misinformation – or ‘infodemic – is not new, it has blown out […] Continue reading ->
Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading ->
The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading ->
Part of a series of stories about how the coronavirus lockdowns and relaxations are playing out in different parts of Africa. For more on this, see our stories on South Africa and Ibadan, Nigeria. Kampala, Uganda – As Uganda’s coronavirus cases double in only two weeks, the Ministry of Health is considering a second lockdown […] Continue reading ->
European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading ->
Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading ->
Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading ->
A new study by researchers at the University of Hong Kong (HKU) has documented how poor building ventilation plays a role in indoor transmission of Covid-19. The study looked at the air flow and infection dynamics from three important Covid-19 outbreaks in China and Japan, concluding that spread of the virus was “definitely favored by poor air […] Continue reading ->
Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view. WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading ->
BREAKING – The United States on Tuesday gave formal notice to the United Nations and the US Congress that it intends to withdraw from the World Health Organization as of 6 July 2021, following President Donald Trump’s announcement after the World Health Assembly on 18 May. The administration first notified the United Nations, and sent […] Continue reading ->